SE433492B - Sett att framstella fenylettiksyraderivat - Google Patents

Sett att framstella fenylettiksyraderivat

Info

Publication number
SE433492B
SE433492B SE7613651A SE7613651A SE433492B SE 433492 B SE433492 B SE 433492B SE 7613651 A SE7613651 A SE 7613651A SE 7613651 A SE7613651 A SE 7613651A SE 433492 B SE433492 B SE 433492B
Authority
SE
Sweden
Prior art keywords
phenyletic
make
acid derivatives
derivatives
acid
Prior art date
Application number
SE7613651A
Other languages
English (en)
Other versions
SE7613651L (sv
Inventor
K Noda
A Nakagawa
Y Ishikura
H Ide
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of SE7613651L publication Critical patent/SE7613651L/sv
Publication of SE433492B publication Critical patent/SE433492B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7613651A 1975-12-24 1976-12-06 Sett att framstella fenylettiksyraderivat SE433492B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50156799A JPS5826744B2 (ja) 1975-12-24 1975-12-24 シンキナプロピオンサン エステルユウドウタイノセイゾウホウ

Publications (2)

Publication Number Publication Date
SE7613651L SE7613651L (sv) 1977-06-25
SE433492B true SE433492B (sv) 1984-05-28

Family

ID=15635562

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613651A SE433492B (sv) 1975-12-24 1976-12-06 Sett att framstella fenylettiksyraderivat

Country Status (9)

Country Link
JP (1) JPS5826744B2 (sv)
AU (1) AU507661B2 (sv)
CA (1) CA1076134A (sv)
CH (1) CH617919A5 (sv)
DE (1) DE2658610C2 (sv)
FR (1) FR2336126A1 (sv)
GB (1) GB1573322A (sv)
NL (1) NL180381C (sv)
SE (1) SE433492B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517358A (en) * 1978-07-24 1980-02-06 Teikoku Seiyaku Kk Butyl propionate derivative, its preparation, and antiphlogistic and analgesic comprising it
JPS54144336A (en) * 1978-07-24 1979-11-10 Teikoku Seiyaku Kk Propionic acid propylester derivative*its manufacture and antiiinflammatory and sedative agent containing it
JPS5587770A (en) * 1978-12-27 1980-07-02 Hisamitsu Pharmaceut Co Inc Preparation of 2-(p-isobutylphenyl)propionic acid 2-pyridinemethyl ester
JPS57203035A (en) * 1981-06-05 1982-12-13 Taisho Pharmaceut Co Ltd Carboxylic acid ester
DE3225290A1 (de) * 1982-07-07 1984-01-12 Merck Patent Gmbh Ringverbindungen
YU43408B (en) * 1985-04-26 1989-06-30 Lek Tovarna Farmacevtskih Process for preparation of 2-(4-isobuthylphenyl)-prophiohydroxamic acid
JPH0635378B2 (ja) * 1985-06-27 1994-05-11 ポ−ラ化成工業株式会社 化粧料
ES2004447A6 (es) * 1987-07-06 1989-01-01 Sune Coma Nuria Procedimiento de obtencion de un nuevo ester del acido 2-(p-isobutilfeni)-propionico
DE3811118C1 (sv) * 1988-03-31 1989-10-12 Merckle Gmbh, 7902 Blaubeuren, De
IT1217589B (it) * 1988-05-13 1990-03-30 Pulitzer Italiana Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica,sua preparazione e relative composizioni farmaceutiche
JPH0639449B2 (ja) * 1989-04-10 1994-05-25 エーザイ株式会社 ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
EP0584108B1 (en) 1991-05-13 2000-08-16 The Boots Company PLC Pharmaceutical composition comprising ibuprofen salt
US6399618B1 (en) * 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
CN103948571A (zh) * 2006-07-18 2014-07-30 天津昕晨泰飞尔医药科技有限公司 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药
CN101506161B (zh) * 2006-08-15 2013-11-13 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
EP2773378B1 (en) 2011-10-31 2016-08-10 Larsen, Claus Selch Prodrugs of non-steroid anti-inflammatory agents (nsaids)
US9470448B2 (en) 2012-12-13 2016-10-18 Whirlpool Corporation Apparatus to warm plastic side of mold
US9273891B2 (en) 2012-12-13 2016-03-01 Whirlpool Corporation Rotational ice maker
US9557087B2 (en) 2012-12-13 2017-01-31 Whirlpool Corporation Clear ice making apparatus having an oscillation frequency and angle
US9500398B2 (en) 2012-12-13 2016-11-22 Whirlpool Corporation Twist harvest ice geometry
CN105461731B (zh) * 2014-08-07 2017-05-24 富力 连翘脂素布洛芬酯、其制备及其应用
WO2016065269A2 (en) 2014-10-23 2016-04-28 Whirlpool Corporation Method and apparatus for increasing rate of ice production in an automatic ice maker
JP6153264B2 (ja) * 2015-01-05 2017-06-28 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
CN109134262A (zh) * 2017-06-15 2019-01-04 北京蓝丹医药科技有限公司 一种洛索洛芬衍生物
CN109134261A (zh) * 2017-06-15 2019-01-04 北京蓝丹医药科技有限公司 一种洛索洛芬衍生物
US10907874B2 (en) 2018-10-22 2021-02-02 Whirlpool Corporation Ice maker downspout
KR20230018481A (ko) * 2020-06-05 2023-02-07 테크필즈 인크. 질병의 치료를 위한 2-(다이에틸아미노)에틸 2-(4-아이소부틸페닐)프로피오네이트의 국소 투여

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents

Also Published As

Publication number Publication date
NL180381B (nl) 1986-09-16
DE2658610C2 (de) 1982-12-23
GB1573322A (en) 1980-08-20
NL180381C (nl) 1987-02-16
DE2658610A1 (de) 1977-07-07
SE7613651L (sv) 1977-06-25
FR2336126A1 (fr) 1977-07-22
CH617919A5 (en) 1980-06-30
CA1076134A (en) 1980-04-22
AU507661B2 (en) 1980-02-21
JPS5278848A (en) 1977-07-02
FR2336126B1 (sv) 1979-03-09
NL7614308A (nl) 1977-06-28
AU2087876A (en) 1978-06-29
JPS5826744B2 (ja) 1983-06-04

Similar Documents

Publication Publication Date Title
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE433222B (sv) Sett att framstella modifierad polysackarid
SE441528B (sv) Sett att framstella nya 3-kinolin-karboxylsyraderivat
SE426583B (sv) Sett att framstella etylidenacetat
SE419645B (sv) Sett att framstella 3-amino-indazolkarbonylsyra derivat
SE7606280L (sv) Sett att framstella etrar
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE425736B (sv) Sett att framstella kromanon-(4)
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE434842B (sv) Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat
SE7604890L (sv) Sett att framstella perkarbonsyralosningar
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7607171L (sv) Sett att framstella indolokinoliziner
SE427655B (sv) Sett att framstella abietamidderivat
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE7608939L (sv) Sett att framstella pyrrolinderivat
SE420690B (sv) Sett att kontinuerligt framstella vermeisolerande ledningsror
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE432588B (sv) Sett att framstella substituerade fenyl-alkyl-karboxylsyror

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7613651-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7613651-4

Format of ref document f/p: F